Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns
Michael Adeyemi Olamoyegun, Akinyele Taofiq Akinlade, Michael Bimbola Fawale, Anthonia Okeoghene Ogbera
The Pan African Medical Journal. 2016;25:72. doi:10.11604/pamj.2016.25.72.6496

Create an account  |  Sign in
EPI Helina 2017
"Better health through knowledge sharing and information dissemination "

Research

Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns

Cite this: The Pan African Medical Journal. 2016;25:72. doi:10.11604/pamj.2016.25.72.6496

Received: 10/03/2015 - Accepted: 04/08/2016 - Published: 04/10/2016

Key words: Stroke, dyslipidaemia, risk factors, prevalence, patterns

© Michael Adeyemi Olamoyegun et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Available online at: http://www.panafrican-med-journal.com/content/article/25/72/full

Corresponding author: Michael Adeyemi Olamoyegun, Department of Internal Medicine, Endocrinology, Diabetes & Metabolism Unit, LAUTECH Teaching Hospital, and College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria (dryemi@yahoo.com)


Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns

Michael Adeyemi Olamoyegun1,&, Akinyele Taofiq Akinlade2, Michael Bimbola Fawale3, Anthonia Okeoghene Ogbera4

 

1Department of Internal Medicine, Endocrinology, Diabetes & Metabolism Unit, LAUTECH Teaching Hospital, and College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria, 2Department of Medicine, General Hospital, Odan, Lagos, Lagos State, Nigeria, 3Department of Medicine, Obafemi Awolowo University Teaching Hospital Complex, and Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria, 4Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos state

 

 

&Corresponding author
Michael Adeyemi Olamoyegun, Department of Internal Medicine, Endocrinology, Diabetes & Metabolism Unit, LAUTECH Teaching Hospital, and College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria

 

 

Abstract

Introduction: stroke is a major public health problem worldwide. Hypertension, diabetes mellitus, dyslipidaemia and smoking are some of the common modifiable risk factors in the occurrence of stroke. Therefore, this study was designed to assess the prevalence and patterns of dyslipidaemia among individuals with acute stroke.

 

Methods: this is a retrospective descriptive cross-sectional study, carried out in the Departments of Medicine at the LAUTECH Teaching hospital, Ogbomoso and General Hospital, Orile-Agege, Lagos, South-West, Nigeria, over a 18-month period between September 2012 and February 2014. One hundred and six (106) patients with acute stroke confirmed with computed tomography (CT) brain scan were recruited. Clinical features, risk factors, lipid profiles and stroke patterns were identified.

 

Results: mean age was significantly higher in ischaemic stroke compared to haemorrhagic (64.08±10.87 Vs, 56.21±12.38years, p=0.001). There was slight male preponderance in both stroke types (1.3:1). Out of 106 patients, 65 (61.3%) had ischaemic stroke, 38 (35.8%) intracerebral haemorrhage and 3 (2.9%) with subarachnoid haemorrhage. Dyslipidaemia is the most frequent risk factor (85.9%), followed by hypertension (66.0%) and diabetes mellitus (15.1%). Dyslipidaemia was significantly higher in the ischaemic stroke compared to haemorrhagic. Reduced HDL-cholesterol is the most prevalent fraction of lipid abnormalities (74.5%).

 

Conclusion: Dyslipidaemia, particularly low HDL-C, was the most frequent risk factor in our patients with stroke. Hence, prevention of dyslipidaemia as well as other risk factors is key to reducing the burden of stroke in our country.

 

 

Introduction    Down

Stroke is defined as a rapidly developed global or focal neurological deficit lasting more than 24 hours or leading to death with no apparent cause other than vascular origin [1]. It is the leading cause of mortality and long-term disability worldwide with up to one of every six survivors remaining permanently disabled [2]. In industrialised countries, stroke accounts for about 10% of all deaths [3]. In Nigeria, the frequency of stroke hospitalization ranges from 0.9 to 4.0%, 0.5 to 45% of neurological admissions, 3.7% of emergency medical admission, and found to be eighth leading cause of death [4, 5]. Of all strokes, 88% are classified as ischaemic, and remaining 12% comprise of haemorrhagic, either subarachnoid (9%) or intracerebral (3%) [6]. Hypertension (HTN), atrial fibrillation, other cardiac diseases, dyslipidaemia, diabetes mellitus (DM), cigarette smoking, physical inactivity, carotid stenosis, and transient ischemic attack (TIA) are all modifiable risk factors that predispose to stroke [7]. Dyslipidaemia is the presence of abnormal levels of lipids or lipoproteins in the blood, which includes elevated total cholesterol (TC), elevated low density lipoprotein cholesterol (LDL-C), elevated triglycerides (TG) and reduced high density lipoprotein cholesterol (HDL-C) [8]. Dyslipidaemia, especially elevated levels of LDL-C is a major risk factor for cerebral infarction by promoting formation of atherosclerosis [9, 10]. Atherosclerosis is the most important pathologic event among cardiovascular (CV) diseases and dyslipidaemia is one of the most important risk factors for developing atherosclerosis. Stroke has been shown to be related to blood lipid levels [11, 12]. Hence reducing LDL level to target can significantly reduce the risk of cerebral infarction and stroke [13]. However, the role of dyslipidaemia in the pathogenesis of haemorrhagic stroke is not clear, it has been suggested that elevated level of LDL might increase the risk of haemorrhagic stroke [14]. In Nigeria and, indeed, sub-Saharan Africa, there is inadequate data on the prevalence and patterns of lipids in relation to stroke phenotype, hence this study was aimed to ascertain the association between dyslipidaemia and stroke subtypes among patients who presented in our centres.

 

 

Methods Up    Down

This was a retrospective descriptive study carried out on patients with history and examination in keeping with acute stroke during an 18-month period between September, 2012 and February, 2014. Patients were recruited from the departments of Medicine of LAUTECH Teaching Hospital, Ogbomoso and General Hospital, Orile-Agege, Lagos. Both hospitals are located within South-West, Nigeria. The study protocol was approved by the Ethics and Research Committee of the LAUTECH Teaching Hospital. Patients under drugs that treat dyslipidaemia were excluded. Stroke was defined and categorized into hemorrhagic and ischemic stroke based on brain computerized tomography (CT) scan findings. Fasting lipid profile including total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglycerides (TG) levels expressed in mg/dL were also obtained from the records. Only patients whose blood samples for lipid profile were collected within 72 hours of presenting in the hospital were recruited into the study. Lipid abnormality was defined as raised TG level ≥ 150mg/dL, reduced HDL-Cholesterol - <40mg/dL in males and < 50mg/dL in females and TC level ≥ 200mg/dL [15]. The atherogenic index and lipid ratios were calculated using the following established formulas [16, 17].

 

Atherogenic index of plasma (AIP) = Log [TG/ HDLc

 

Castelli Risk Index − I (CRI'>TG/ HDLc

 

Castelli Risk Index − I (CRI- I) = TC/ HDLc

 

Castelli Risk Index − II (CRI- II) = LDLc/ HDLc

 

Atherogenic co − efficient (AC) = TG - HDLc / HDLc

 

CHOLIndex = LDLc − HDLc [TG < 400]
= LDLc − HDLc + 1/5TG [TG > 400 >TG > 400]

 

The following are the abnormal values of atherogenic index of plasma, lipid ratios, and CHOLIndex for cardiovascular risk: AIP > 0.1, CRI−I > 3.5 in males and >3.0 in females, CRI−II > 3.3, AC > 3.0 and CHOLIndex > 2.07 [16, 18-20].

 

Data analysis

 

The data obtained from the study was analyzed using Statistical Package for Social Sciences version 16 (SPSS vs. 16) for Windows. Descriptive statistics were presented as mean ± standard deviation (SD), range and frequency (% values). For comparisons between two groups, independent sample t test was used for normally distributed numerical variables. After performing homogeneity of means test, Oneway Anova was used for comparisons between multiple independent groups. Chi-square test was used for categorical variables. Statistical significance was set at P <0.05. Multivariate logistic regression analysis was done to determine the factors that predict or differentiate subtypes of stroke.

 

 

Results Up    Down

A total of 106 patients participated in our study comprising of 61 (57.5%) males. The mean age was 56.21 ± 12.38 and 64.08 ± 10.87 years for the hemorrhagic and ischemic stroke patients respectively. Sixty-five (61.3%) of the patients had Ischemic stroke, 38 (35.8%) hemorrhagic stroke, while 3 (2.9%) patients had subarachnoid haemorrhage (Figure 1). The history of diabetes, hypertension, angina pectoris and intermittent claudication were commoner in patients with ischemic stroke compared with hemorrhagic stroke as shown in Table 1. Of all the admission signs and symptoms, headache, vomiting and loss of consciousness were significantly higher among the hemorrhagic stroke patients compared to those with ischemic stroke (23 vs. 12; p=<0.001, 18 vs. 9; p=<0.001, 21 vs. 20; p=0.013) respectively. Incidence of stroke increases with age (Figure 2). The incidence of ischemic stroke peaks in the 60 - 69 years age group while it peaks in the 50 - 59 years age group for the hemorrhagic stroke. In both groups, about 60.4% of the patients were more than 60 years old. Figure 3 shows the abnormal lipid profiles in the two major subcategories. Table 2 shows the clinical and biochemical characteristics of the patients. The admission systolic blood pressure (SBP) was significantly higher in the hemorrhagic stroke patients (183.03±33.99 vs. 159.46±31.87; p=0.001). All the other parameters were higher in the ischemic stroke patients than in the hemorrhagic stroke patients apart from the admission diastolic blood pressure (DBP), although this difference was not statistically significant. On evaluation of the atherogenic index of plasma and the lipid ratios, they were higher in the ischemic stroke patients, although this difference was not statistically significant (Table 2). On logistic regression, only Siriraj score independently differentiated ischaemic stroke from haemorrhagic stroke (OR=6) (Table 3).

 

 

Discussion Up    Down

The prevalence and pattern of dyslipidaemia among stroke patients in Nigeria has not been sufficiently studied, justifying this study. This retrospective study showed that the incidence of stroke increased with age and the peak incidence for ischaemic and haemorrhagic strokes were in the 7th and 6th decades respectively. This shows that older patients developed more ischaemic stroke compared to haemorrhagic stroke. This trend suggests that increasing age (or risk factors associated with age) increases the risk of an infarction more than it does haemorrhagic stroke. This is similar to findings in other studies in Nigeria [21, 22] and in the United State of America [23]. The male to female sex ratio of 1.3:1 is in keeping with other studies that reported male preponderance [21, 22]. The male sex has been listed as a risk factor for stroke [24]. There was a higher incidence of ischaemic stroke (61.3%) than haemorrhagic stroke (35.8%). This is in keeping with a study in South-West Nigeria which also reported higher prevalence of ischaemic stroke compared to haemorrhagic stroke [25] and 65% versus 31% reported by Eze et al [21]. Sixty-five (61.3%) had ischaemic stroke compared to 39 (35.8%) and 3 (%) with haemorrhagic stroke and SAH respectively. This is similar to Desalu et al [25] which reported 64%, 31% and 3% for ischaemic, haemorrhagic and SAH respectively.

 

In our study, we observed that, besides age, dyslipidaemia was the most frequent risk factor (85.9%), followed by hypertension (66.0%) and hyperglycaemia (15.1%), constituting major risk factors in our stroke patients. Khan et al [26] found hypertension (65%), dyslipidaemia (32.7%), DM (31.3%) and smoking (32%) as major risk factors for stroke. The prevalence of hypertension reported in this study is lower than 86.5% reported by Desalu et al [25] in South-West Nigeria and 76% reported by Eze et al [21] in Abakaliki, South-Eastern Nigeria. The prevalence of DM (15.1%) in this study is also lower than 23.8% reported in South-West, Nigeria by Desalu et al [25] where DM was ranked second, but higher than 8% reported in North-Eastern Nigeria by Ogun et al [27]. The presence of DM was significantly higher among those with ischaemic stroke compared with haemorrhagic stroke. DM is a major risk factor for the development of atherosclerosis, an important pathologic mechanism in the development of ischaemic stroke. Excess risk of stroke in patients with DM is about 2-4 times higher compared with individuals in a general population without diabetes [28].

 

We found that, overall, the prevalence of dyslipidaemia in our study sample as whole was 85.9%. The prevalence of dyslipidaemia in ischaemic stroke (92.3%) was significantly higher than in haemorrhagic (81.6%). Mirghan & Zein [29] found that the prevalence of dyslipidaemia in ischaemic stroke patients in Emarates [30] was 65% which is lower than in our finding. These differences in the prevalence of dyslipidaemia in different places may be attributed to the differences in genetic pattern, cultures, lifestyles and dietary habits. The high prevalence of dyslipidaemia in our study may also be attributed to the possibility of insulin resistance in our subjects, since most of our patients are hypertensive (66%).

 

As regard the patterns of dyslipidaemia in our study, low HDL-C is the most prevalent pattern in our study (74.5%), followed by elevated LDL-C (7.5%), high TC (5.7%) and elevated TG (4.7%). There was no significant difference in the pattern of lipids among ischaemic stroke compared to haemorrhagic stroke, although all lipid parameters were higher in ischaemic stroke compared to haemorrhagic stroke. This is in conformity with other Nigerian studies [31-34], that also found a very high prevalence of low LDL-C in their participants, as the most prevalent lipid abnormality. Our findings, however, differ from those in Caucasian populations, where reduced HDL-C was said to be uncommon in ATP III [15]. It is also different from a previous study by Zhang et al [35] that found high LDL-C as the most prevalent dyslipidaemia among ischaemic stroke. Low levels of HDL-C has been shown to be associated with increased risk of stroke especially ischaemic stroke as reported by several studies [36, 37] that found an inverse association between HDL-C and ischaemic stroke risk in both gender.

 

Regarding lipid ratios, both CRI-I (TC/HDL-C) and CRI-II (log [TC/LDL-C]), were significantly higher among patients with ischaemic stroke compared to those with haemorrhagic. Zhang et al [38] found a positive association between elevated CRI-I and ischaemic stroke.

 

 

Conclusion Up    Down

Evidence from this study suggests that dyslipidaemia, followed by hypertension and diabetes, is the most frequent stroke risk factor in our sample. Although elevated LDL-C is usually the lipid fraction implicated in the pathologic mechanism of stroke, our study showed a significant proportion of our study subjects had reduced HDL-C. Hence, control of dyslipidaemia should be targeted in the primary prevention of stroke in order to reduce the burden of stroke in our country.

What is known about this topic

  • Dyslipidaemia is one of the modifiable risk factors for the development of stroke;
  • Elevated low density lipoprotein cholesterol (LDL-C) is the lipid subtype most implicated in the pathologic mechanism of stroke.

What this study adds

  • Dyslipidaemia is the most frequent risk factor (85.9%) found in those with stroke, followed by hypertension (66.0%);
  • Reduced high density lipoprotein cholesterol (HDL-C) is the most prevalent fraction of lipid abnormalities (74.5%), followed by elevated LDL (7.5%), elevated total cholesterol (5.7%) & high triglycerides (4.7%);
  • Castelli risk index (CRI-I)-TC/HDL and Castelli risk index-II (Log [TC/LDL-C]) significantly higher among patients with ischaemic stroke compared with those with haemorrhagic subtype.

 

 

Competing interests Up    Down

The authors decalre no competing interests.

 

 

Authors’ contributions Up    Down

MAO and AAT conceptualized the design of the manuscript, data collections, and drafting of the manuscript. MBF was involved in the statistical analysis. AO was involved in the statistical expertise and manuscript draft. All authors read and approved final draft of the manuscript.

 

 

Tables and figures Up    Down

Table 1: the admission presentation of the stroke patients

Table 2: a comparison of clinical and biochemical parameters of the patients with Hemorrhagic and Ischemic stroke

Table 3: logistic regression of the predictors of stroke subtype

Figure 1: summary of the number of stroke cases

Figure 2: age distribution of the stroke subtypes

Figure 3: abnormal Lipid profile among the two major subcategory of stroke patients

 

 

References Up    Down

  1. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: Result of WHO collaborative study. Bull World Health Organ. 1980; 58(1):113-30. PubMed | Google Scholar

  2. Klijn CJM, Hankey GJ. Management of acute Ischemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol. 2003; 2(11):698 - 701. PubMed | Google Scholar

  3. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Kase C et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007; 116:e391-413. PubMed | Google Scholar

  4. Ojini FI, Danesi MA. Pattern of neurological admissions at the Lagos University Teaching Hospital. Nig J Clin Pract. 2003; 5(1):38-41. PubMed | Google Scholar

  5. World Health Organisation (WHO) Country mortality Fact Sheet 2006 Nigeria. Death and DALY estimates by cause, 2002. Available at http://www.who.int/entity/healthinfo/statistics/bodgbddeathdalyestimates.xis Accessed on March 10, 2015. Google Scholar

  6. American Heart Association. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Committee. Circulation. 2006; 113(6): e85-e151. PubMed | Google Scholar

  7. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(2):517-84. PubMed | Google Scholar

  8. Mohiuddin SM, Pepine CJ, Kelly MT et al. Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidaemia: a phase 3, randomized, controlled study. American Heart Journal. 2009; 157(1):195-203. PubMed | Google Scholar

  9. Paciaroni M, Hennerici M, Angelli G et al. Statin and stroke prevention. Cerebrovascular dis. 2007; 24(2-3):170-182. PubMed | Google Scholar

  10. Xing XY, Li GW, Yao CH et al. The association of stroke high plasma low density lipoprotein cholesterol level and metabolic syndrome in Chinese adults. Chin J Intern Med. 2009; 48(5):388-391. PubMed | Google Scholar

  11. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989; 320(14): 904-10. PubMed | Google Scholar

  12. Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence in Hawaii Japanese men: the Honolulu Heart Study. Stroke. 1980; 11(1): 14-21. PubMed | Google Scholar

  13. Hanky GJ, Spiesser J, Hakimi Z, et al. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurol. 2007; 68(19): 1583-7. PubMed | Google Scholar

  14. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidaemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J. 2008; 156(1): 112-9. PubMed | Google Scholar

  15. Executive summary of the third report of National Cholesterol Education Program, expert panel on detection, evaluation and treatment of high blood cholesterol in adults ( adult treatment panel - III of National Cholesterol Education Program. JAMA. 2001; 285:2486 - 2497. Google Scholar

  16. Akp'nar O, Bozkurt A, Acartürk E et al. A new index (CHOLINDEX) in detecting coronary artery disease risk. Anadolu Kardiyol Derg. 2013; 13(4):315-9. PubMed | Google Scholar

  17. Girish MD, Raghunandan R, Kiran KA et al. A Cross Sectional Study of Serum Gamaglutamyl Transferase Activity with Reference to Ahterogenic Lipid Indices in Patients with Ischemic Heart Disease. Journal of Evolution of Medical and Dental Sciences. 2014; 3(10):2655-2662. PubMed | Google Scholar

  18. Bhardwaj S, Bhattacharjee J, Bhatnagar MK et al. Atherogenic index of plasma, Castelli risk index and atherogenic coefficient- new parameters in assessing cardiovascular risk. Int J Pharm Bio Sci. 2013; 3(3):359-364. PubMed | Google Scholar

  19. Dobiasova M. AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006; 52(1):64-71. PubMed | Google Scholar

  20. Thiruvelan. Cholesteroal ratios.http://healthy-ojas.com/cholesterol/cholesterol-ratios.html. Accessed on March 10, 2015. Google Scholar

  21. Eze CO, Agu CE, Kalu UA, Maduanusi CA, Nwali ST, Igwenyi C. The Pattern and Presentation of Stroke in Federal Teaching Hospital Abakaliki (FETHA) South-East Nigeria. Journal of Biology, Agriculture and Healthcare. 2013; 3(11): 141- 144. PubMed | Google Scholar

  22. Owolabi LF, Nagoda M. Stroke in developing countries: experience at Kano, Northwestern Nigeria. Sudan J of Med Sc. 2012; 7(1); 9-14. PubMed | Google Scholar

  23. Jacobs BS, Boden-AIbala B, Lin IF, Sacco RF. Stroke in the young in the Northern Manhattan Stroke Study. Stroke. 2002; 33(12); 2789-2793. PubMed | Google Scholar

  24. Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk. 1999; 6(4): 217-221. PubMed | Google Scholar

  25. Desalu OO, Wahab KW, Fawale B, Olarenwaju TO, Busari OA, Adekoya AO et al. A review of stroke admissions at a tertiary hospital in rural Southwestern Nigeria. Annals of African Medicine. 2011; 10(2); 80-85. PubMed | Google Scholar

  26. Khan NI, Naz L, Mushtaq S et al. Ischemic stroke: prevalence of modifiable risk factors in male and female patients in Pakistan. 64 Pak J Pharm Sci. 2009; 22(1); 62-67. PubMed | Google Scholar

  27. Ogun SA, Ojini FI, Ogungbo B, Kolapo KO, Danesi MA. Stroke in South West Nigeria: A 10-Year Review. Stroke. 2005; 36(6); 1120-1122. PubMed | Google Scholar

  28. Hasan SR, Khan GAS. Frequency of known risk factors of stroke and its outcome in patients admitted in Sindh Government Qatar hospital Karachi. Pak J Med Sci. 2007; 23: 634-636. PubMed | Google Scholar

  29. Mirghani Z, Zein T. Total and LDL cholesterol as risk factors of ischemic stroke in Emirati patients. The Internet Journal of Neurology. 2010; 13:1. PubMed | Google Scholar

  30. Smolders B, Lemmens R, Thijs V. Lipoprotein A and stroke: a meta-analysis of observational studies. Stroke. 2007; 38(6):1959-66. PubMed | Google Scholar

  31. Akintunde AA, Ayodele EO, Akinwusi OP, Opadijo GO. Dyslipidemia among newly diagnosed hypertensives: pattern and clinical correlates. J Natl Med Assoc. 2010; 102(5):403-407. PubMed | Google Scholar

  32. Osuji CU, Omejua EG, Onwubuya EI, Ahaneku GI. Serum lipid profile of newly diagnosed hypertensive patients in Nnewi, South-East Nigeria. Int J Hypertens. 2012; 2012:710486. PubMed | Google Scholar

  33. Adediran SO, Akintunde AA, Opadijo OG, Araoye MA. Dyslipidaemia, Atherogenic Index and urbanization in central Nigeria: Associations, Impact, and a call for concerted action. Int J Cardiovasc Res. 2013; 2:4. PubMed | Google Scholar

  34. Ogbera AO, Oshinaike OO, Dada O, Brodie-Mends A, Ekpebegn C. Glucose and lipid assessment in patients with acute stroke. Int Arch Med. 2014; 7(1): 45. PubMed | Google Scholar

  35. Zhang X, Sun Z, Zhang X et al. Gender differences in blood lipids and the risk of ischemic stroke among the hypertensive adults in rural China. Neurol India. 2007; 55(4):338-42. PubMed | Google Scholar

  36. Woodward M, Barzi F, Feigin V et al. For the Asia Pacific Cohort Studies Collaboration, Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007; 28(21): 2653-60. PubMed | Google Scholar

  37. Zhang Y, Tuomilehto J, Jousilahti P et al. Total and high-density lipoprotein cholesterol and stroke risk. Stroke. 2012; 43(7):1768-74. PubMed | Google Scholar

  38. Zhang Y, Tuomilehto J, Jousilahti P et al. Total and high-density lipoprotein cholesterol and stroke risk. Stroke. 2012; 43(7):1768-74. PubMed | Google Scholar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


The Pan African Medical Journal articles are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 26 (Jan - Apr 2017)

Article tools

PDF in process
Log in to comment
Contact the corresponding author
Download to Citation Manager
EndNote
Reference Manager
Zotero
BibTex
ProCite


Rate this article

Altmetric

PAMJ is a member of the Committee on Publication Ethics

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2017 - Pan African Medical Journal. All rights reserved